ANG Lifesciences appoints Preeti Sarin as Additional Independent Director for five-year term
BSE India
ANG Lifesciences board approves the appointment of Mrs. Preeti Sarin as an Additional Independent Director for a five-year term effective November 14, 2026. The board also takes note of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The appointment follows the recommendation of the Nomination & Remuneration Committee and remains subject to shareholder approval.
| Sep 2026 | Jun 2026 | Sep 2025 | QoQ% | YoY% | |
|---|---|---|---|---|---|
| Revenue/Sales | 20.10 | 15.30 | 26.05 | 31.39% | -22.85% |
| EBITDA | -0.15 | -1.85 | 0.20 | 91.62% | -176.38% |
| Op. profit margin(%) | -1.31 | -12.77 | 0.31 | 89.73% | -527.63% |
| Net Profit | -2.09 | -4.24 | -2.95 | 50.79% | 29.14% |
| EPS | -1.59 | -3.24 | -2.24 | 50.93% | 29.02% |
* Consolidated data